(Q36204035)

12 August 2017

1 reference

title

Post-Amadori AGE inhibition as a therapeutic target for diabetic complications: a rational approach to second-generation Amadorin design (English)

1 reference

12 August 2017

Raja G Khalifah

1

1 reference

12 August 2017

Ying Chen

series ordinal

2

1 reference

12 August 2017

James J Wassenberg

series ordinal

3

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

Annals of the New York Academy of Sciences

12 August 2017

published in

1 reference

12 August 2017

volume

1043

1 reference

12 August 2017

page(s)

793-806

1 reference

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.092

Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.092

Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.092

The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.092

Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.092

Role of lipids in chemical modification of proteins and development of complications in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.092

Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.092

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.092

Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.092

Nonenzymatic browning in vivo: possible process for aging of long-lived proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.092

Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.092

A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.092

Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.092

Effect of antioxidants and ACE inhibition on chemical modification of proteins and progression of nephropathy in the streptozotocin diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.092

Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.092

Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.092

Formation of reactive intermediates from Amadori compounds under physiological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.092

The enzymatic defence against glycation in health, disease and therapeutics: a symposium to examine the concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.092

Proteomic analysis of the site specificity of glycation and carboxymethylation of ribonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.092

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1333.092

1 reference

12 August 2017

1 reference